The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases
CompletedOBSERVATIONAL
Enrollment
130
Participants
Timeline
Start Date
October 31, 1977
Study Completion Date
November 30, 2001
Conditions
Basal Cell CarcinomaKeratosis Palmaris et PlantarisPsoriasis
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00005660 - The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases | Biotech Hunter | Biotech Hunter